Phylos Validates Technology for Protein Chips In Scientific Journal Article, Receives Patent | GenomeWeb

With a newly granted patent and a newly published article validating its protein binding technology, Lexington, Mass.-based Phylos is readying to attack the protein chip market.

The US patent, "Systematic Polypeptide Evolution by Reverse Translation," describes a method for developing libraries of nucleic-acid-polypeptide molecules that can serve as binding sites for target protein molecules.

Get the full story with
GenomeWeb Premium

Only $95 for the
first 90 days*

A trial upgrade to GenomeWeb Premium gives you full site access, interest-based email alerts, access to archives, and more. Never miss another important industry story.

Try GenomeWeb Premium now.

Already a GenomeWeb Premium member? Login Now.
Or, See if your institution qualifies for premium access.

*Before your trial expires, we’ll put together a custom quote with your long-term premium options.

Not ready for premium?

Register for Free Content
You can still register for access to our free content.